Online inquiry

IVTScrip™ mRNA-Human neurofilament heavy (200 kDa), (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9602MR)

This product GTTS-WK9602MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methoxy-UTP. It ecodes the neurofilament heavy (200 kDa) protein. This product can be used in Neuron-related researches.
Specifications
Product type mRNA
Modified bases 5-Methoxy-UTP
5' Cap Cap 0
Species Human
RefSeq NM_021076.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 4744
UniProt ID P12036
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human neurofilament heavy (200 kDa), (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) (GTTS-WK9602MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27526MR IVTScrip™ mRNA-Human ASPRV1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASPRV1
GTTS-WK11701MR IVTScrip™ mRNA-Human neurofilament medium (160 kDa), (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA neurofilament medium (160 kDa)
GTTS-WK0343MR IVTScrip™ mRNA-Human COL11A1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA COL11A1
GTTS-WK17535MR IVTScrip™ mRNA-Human Alpha-actinin, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Alpha-actinin
GTTS-WK10502MR IVTScrip™ mRNA-Human neurofilament heavy (200 kDa), (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA neurofilament heavy (200 kDa)
GTTS-WK1417MR IVTScrip™ mRNA-Human Nestin, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA Nestin
GTTS-WK12765MR IVTScrip™ mRNA-Human ACTN1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTN1
GTTS-WK7502MR IVTScrip™ mRNA-Human neurofilament heavy (200 kDa), (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA neurofilament heavy (200 kDa)
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.